Literature DB >> 23429261

pRb/E2F-1-mediated caspase-dependent induction of Noxa amplifies the apoptotic effects of the Bcl-2/Bcl-xL inhibitor ABT-737.

J Bertin-Ciftci1, B Barré, J Le Pen, L Maillet, C Couriaud, P Juin, F Braun.   

Abstract

Although Bcl-2 family members control caspase activity by regulating mitochondrial permeability, caspases can, in turn, amplify the apoptotic process upstream of mitochondria by ill-characterized mechanisms. We herein show that treatment with a potent inhibitor of Bcl-2 and Bcl-xL, ABT-737, triggers caspase-dependent induction of the BH3-only protein, Mcl-1 inhibitor, Noxa. RNA interference experiments reveal that induction of Noxa, and subsequent cell death, rely not only on the transcription factor E2F-1 but also on its regulator pRb. In response to ABT-737, pRb is cleaved by caspases into a p68Rb form that still interacts with E2F-1. Moreover, pRb occupies the noxa promoter together with E2F-1, in a caspase-dependent manner upon ABT-737 treatment. Thus, caspases contribute to trigger the mitochondrial apoptotic pathway by coupling Bcl-2/Bcl-xL inhibition to that of Mcl-1, via the pRb/E2F-1-dependent induction of Noxa.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23429261      PMCID: PMC3619243          DOI: 10.1038/cdd.2013.6

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  49 in total

1.  Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737.

Authors:  Victoria Del Gaizo Moore; Jennifer R Brown; Michael Certo; Tara M Love; Carl D Novina; Anthony Letai
Journal:  J Clin Invest       Date:  2007-01       Impact factor: 14.808

2.  Caspase-dependent cleavage of the retinoblastoma protein is an early step in neuronal apoptosis.

Authors:  A L Boutillier; E Trinh; J P Loeffler
Journal:  Oncogene       Date:  2000-04-27       Impact factor: 9.867

Review 3.  E2F - at the crossroads of life and death.

Authors:  Shirley Polager; Doron Ginsberg
Journal:  Trends Cell Biol       Date:  2008-09-18       Impact factor: 20.808

4.  Inhibitors of histone deacetylases target the Rb-E2F1 pathway for apoptosis induction through activation of proapoptotic protein Bim.

Authors:  Yan Zhao; Jing Tan; Li Zhuang; Xia Jiang; Edison T Liu; Qiang Yu
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-21       Impact factor: 11.205

5.  Differences in the mechanisms of proapoptotic BH3 proteins binding to Bcl-XL and Bcl-2 quantified in live MCF-7 cells.

Authors:  Alexander Aranovich; Qian Liu; Tony Collins; Fei Geng; Sudeepa Dixit; Brian Leber; David W Andrews
Journal:  Mol Cell       Date:  2012-03-30       Impact factor: 17.970

6.  Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation.

Authors:  K Helin; C L Wu; A R Fattaey; J A Lees; B D Dynlacht; C Ngwu; E Harlow
Journal:  Genes Dev       Date:  1993-10       Impact factor: 11.361

7.  Chemotherapeutic drugs sensitize human renal cell carcinoma cells to ABT-737 by a mechanism involving the Noxa-dependent inactivation of Mcl-1 or A1.

Authors:  Henry Zall; Arnim Weber; Robert Besch; Niko Zantl; Georg Häcker
Journal:  Mol Cancer       Date:  2010-06-24       Impact factor: 27.401

8.  ABT-737 induces expression of the death receptor 5 and sensitizes human cancer cells to TRAIL-induced apoptosis.

Authors:  Jin H Song; Karthikeyan Kandasamy; Andrew S Kraft
Journal:  J Biol Chem       Date:  2008-07-03       Impact factor: 5.157

Review 9.  The emerging role of E2F-1 in the DNA damage response and checkpoint control.

Authors:  Craig Stevens; Nicholas B La Thangue
Journal:  DNA Repair (Amst)       Date:  2004 Aug-Sep

10.  Bax activation by the BH3-only protein Puma promotes cell dependence on antiapoptotic Bcl-2 family members.

Authors:  Tristan Gallenne; Fabien Gautier; Lisa Oliver; Eric Hervouet; Belinda Noël; John A Hickman; Olivier Geneste; Pierre-François Cartron; François M Vallette; Stephen Manon; Philippe Juin
Journal:  J Cell Biol       Date:  2009-04-20       Impact factor: 10.539

View more
  13 in total

1.  Higher expression of SIRT1 induced resistance of esophageal squamous cell carcinoma cells to cisplatin.

Authors:  Bin Cao; Qintong Shi; Wengong Wang
Journal:  J Thorac Dis       Date:  2015-04       Impact factor: 2.895

2.  E2F1 interacts with BCL-xL and regulates its subcellular localization dynamics to trigger cell death.

Authors:  Céline Vuillier; Steven Lohard; Aurélie Fétiveau; Jennifer Allègre; Cémile Kayaci; Louise E King; Frédérique Braun; Sophie Barillé-Nion; Fabien Gautier; Laurence Dubrez; Andrew P Gilmore; Philippe P Juin; Laurent Maillet
Journal:  EMBO Rep       Date:  2017-12-12       Impact factor: 8.807

Review 3.  Decoding and unlocking the BCL-2 dependency of cancer cells.

Authors:  Philippe Juin; Olivier Geneste; Fabien Gautier; Stéphane Depil; Mario Campone
Journal:  Nat Rev Cancer       Date:  2013-06-20       Impact factor: 60.716

4.  Evaluation and critical assessment of putative MCL-1 inhibitors.

Authors:  S Varadarajan; M Vogler; M Butterworth; D Dinsdale; L D Walensky; G M Cohen
Journal:  Cell Death Differ       Date:  2013-07-05       Impact factor: 15.828

5.  The pro-apoptotic activity of Drosophila Rbf1 involves dE2F2-dependent downregulation of diap1 and buffy mRNA.

Authors:  A Clavier; A Baillet; A Rincheval-Arnold; A Coléno-Costes; C Lasbleiz; B Mignotte; I Guénal
Journal:  Cell Death Dis       Date:  2014-09-04       Impact factor: 8.469

Review 6.  Transcriptional control of stem cell fate by E2Fs and pocket proteins.

Authors:  Lisa M Julian; Alexandre Blais
Journal:  Front Genet       Date:  2015-04-28       Impact factor: 4.599

Review 7.  Artificial intelligence and digital pathology: Opportunities and implications for immuno-oncology.

Authors:  Faranak Sobhani; Ruth Robinson; Azam Hamidinekoo; Ioannis Roxanis; Navita Somaiah; Yinyin Yuan
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2021-02-06       Impact factor: 11.414

8.  Metastatic SW620 colon cancer cells are primed for death when detached and can be sensitized to anoikis by the BH3-mimetic ABT-737.

Authors:  A Maamer-Azzabi; O Ndozangue-Touriguine; J Bréard
Journal:  Cell Death Dis       Date:  2013-09-12       Impact factor: 8.469

9.  Protect and serve: Bcl-2 proteins as guardians and rulers of cancer cell survival.

Authors:  Frédérique Braun; Sophie de Carné Trécesson; Joséphine Bertin-Ciftci; Philippe Juin
Journal:  Cell Cycle       Date:  2013-08-13       Impact factor: 4.534

10.  Mutating RBF can enhance its pro-apoptotic activity and uncovers a new role in tissue homeostasis.

Authors:  Cécile Milet; Aurore Rincheval-Arnold; Angéline Moriéras; Amandine Clavier; Alexandrine Garrigue; Bernard Mignotte; Isabelle Guénal
Journal:  PLoS One       Date:  2014-08-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.